Sonoma Pharmaceuticals (SNOA) Cash from Operations (2010 - 2026)
Sonoma Pharmaceuticals' (SNOA) quarterly Cash from Operations came in at 519000.0 in Q1 2026, down 446.32% year-on-year from 149863.22 in Q1 2025, and up 32.07% quarter-over-quarter from 764000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Cash from Operations (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Cash from Operations history runs 17 years deep, the most recent figure standing at 519000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations fell 446.32% year-over-year to 519000.0 in Q1 2026; TTM through Mar 2026 was 3933000.0, a 4369.32% decrease from a year earlier, with the FY2026 full-year figure at 3933000.0, down 4369.32% from the prior year.
- Cash from Operations advanced to 519000.0 in Q1 2026 per SNOA's latest filing, from 764000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 565000.0 in Q4 2024 and bottomed at 2441000.0 in Q1 2023.
- The 5-year median for Cash from Operations is 764000.0 (2025), against an average of 821529.41.
- Across the five-year window, Cash from Operations jumped 151.18% in 2024 and sank 446.32% in 2026, its largest moves.
- Year by year, Cash from Operations stood at 348000.0 in 2022, then sank by 217.24% to 1104000.0 in 2023, then soared by 151.18% to 565000.0 in 2024, then sank by 235.22% to 764000.0 in 2025, then soared by 32.07% to 519000.0 in 2026.
- Per Business Quant, the three latest SNOA Cash from Operations figures stand at 519000.0 (Q1 2026), 764000.0 (Q4 2025), and 635000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn | -519,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -519,000.00 |
| Mar 31, 2026 | -519,000.00 |
| Dec 31, 2025 | -764,000.00 |
| Dec 31, 2025 | -764,000.00 |
| Sep 30, 2025 | -635,000.00 |
| Sep 30, 2025 | -635,000.00 |
| Jun 30, 2025 | -2.02 Mn |
| Jun 30, 2025 | -2.02 Mn |
| Mar 31, 2025 | -95,000.00 |
| Mar 31, 2025 | -95,000.00 |
| Dec 31, 2024 | 565,000.00 |
| Dec 31, 2024 | 565,000.00 |
| Sep 30, 2024 | 354,000.00 |
| Sep 30, 2024 | 354,000.00 |
| Jun 30, 2024 | -912,000.00 |
| Jun 30, 2024 | -912,000.00 |
| Mar 31, 2024 | 152,000.00 |
| Mar 31, 2024 | 152,000.00 |
| Dec 31, 2023 | -1.10 Mn |
| Dec 31, 2023 | -1.10 Mn |